SS
CNTB

SBI Securities’s Connect Biopharma Holdings CNTB Stock Holding History

SBI Securities’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14 Hold
6
– – ﹤0.01% 3893
2026
Q1 		$16 Hold
6
– – ﹤0.01% 3789
2025
Q4 		$17 Sell
6
-1
-14% -$2 ﹤0.01% 3798
2025
Q3 		$11 Buy
7
+1
+17% +$2 ﹤0.01% 4021
2025
Q2 		$6 Hold
6
– – ﹤0.01% 4053
2025
Q1 		$3 Hold
6
– – ﹤0.01% 4058
2024
Q4 		$8 Buy
+6
New +$7 ﹤0.01% 3948

Other funds holding CNTB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM

SBI Securities's CNTB Position: Q2 2026 in Review

SBI Securities held its Connect Biopharma Holdings (CNTB) position steady in Q2 2026 at 6 shares worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #3893.

SBI Securities first reported a position in CNTB in Q4 2024 and has held it in 7 quarters since. The position peaked at $17 in Q4 2025. 16 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • SBI Securities held 6 shares of Connect Biopharma Holdings worth $14 as of Q2 2026.
  • SBI Securities left its Connect Biopharma Holdings share count unchanged in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3893 holding.
  • SBI Securities first reported a position in Connect Biopharma Holdings in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Connect Biopharma Holdings position peaked at $17 in Q4 2025.
  • 16 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.